Sanofi Aktie
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Kursziele der Sanofi-Aktie in EUR
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| UBS AG | 88,00 EUR | +0,32% | 09.11.2026 | |
| Deutsche Bank AG | 95,00 EUR | +8,30% | 06.11.2026 | |
| DZ BANK | - | - | 04.11.2026 | |
| Bernstein Research | 110,00 EUR | +25,40% | 04.11.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 105,00 EUR | +19,70% | 04.11.2026 | |
| JP Morgan Chase & Co. | 95,00 EUR | +8,30% | 04.11.2026 | |
| RBC Capital Markets | 80,00 EUR | -8,80% | 02.11.2026 | |
| Barclays Capital | 90,00 EUR | +2,60% | 02.11.2026 | |
| Jefferies & Company Inc. | 100,00 EUR | +14,00% | 02.11.2026 | |
| Goldman Sachs Group Inc. | 84,00 EUR | -4,24% | 06.07.2026 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 9 | 1 | 0 | 163,14 GBP | - |
| Bayer | 7 | 2 | 0 | 58,31 EUR | +3,31% |
| BioNTech (ADRs) | 5 | 2 | 0 | 121,84 USD | +42,45% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| EVOTEC SE | 1 | 2 | 0 | 4,08 EUR | +30,94% |
| GSK PLC Registered Shs | 2 | 6 | 2 | 20,52 GBP | +7,94% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 3 | 5 | 0 | 149,00 EUR | +2,34% |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -80,88% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 1 | 7 | 2 | 123,90 CHF | -7,69% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 6 | 1 | 28,43 USD | -2,15% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 5 | 0 | 94,11 EUR | +7,28% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |